Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
ESMO real world data and digital oncology·2026
Increasing Octupole Collectivity across the Z=64 Isotopic Chain: B(E3) Values in ^{150}Gd.
Physical review letters·2025
The role of individual differences in environmental sensitivity in teachers' stress and burnout at work.
Stress and health : journal of the International Society for the Investigation of Stress·2024
Outcomes of CD20-targeting CAR T-cell therapy in patients with advanced melanoma: MB-CART20.1 Melanoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic challenges in WHO classification of thymic epithelial tumors: The clinical value of an international expert pathology panel.
European journal of cancer (Oxford, England : 1990)·2026
A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials.
European journal of cancer (Oxford, England : 1990)·2026
What does addressing cancer inequalities really mean? Five principles that can drive global action.
European journal of cancer (Oxford, England : 1990)·2026
Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial.
European journal of cancer (Oxford, England : 1990)·2026
Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women.
European journal of cancer (Oxford, England : 1990)·2026
Opioid Prescribing Changes in Advanced Cancer Before and After Withdrawal of Hydromorphone Slow-Release Tablets.
Asia-Pacific journal of clinical oncology·2026